Skip to content

Safety evaluation of the capsules containing Valeriana fauriei root (VF) extract.

Safety evaluation in an open-label study of an overdose of the capsules containing Valeriana fauriei root (VF) extract. - Safety evaluation of the capsules containing VF extract.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000049908
Enrollment
10
Registered
2022-12-27
Start date
2023-01-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

Duration:4 weeks Trial food: Soft capsule containing VF extract (1 g/1 capsule) Dosage and administration: Take 10 capsules (equivalent to 10 g of VF extract) with water 30 minutes before bedtime.

Sponsors

Nagoya City University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects with written consent to take part in the trial. 2. Men or women aged 20 to 65. 3. Subjects with ability to take 10 capsules daily. 4. Subjects who can complete the questionnaire via smartphone, tablet, or computer.

Exclusion criteria

Exclusion criteria: 1. Subjects currently being treated for severe renal or liver disease, heart, respiratory or endocrine disease, or other metabolic diseases. 2. Subjects currently taking medications that interfere with sleep (sleeping pills, antianxiety drugs) 3. Subjects allergic to gelatin. 4. Women having the possibility or intention to become pregnant, lactating

Design outcomes

Primary

MeasureTime frame
Adverse effects: number and incidence of adverse effects.

Secondary

MeasureTime frame
1. Adverse effects: number and incidence of adverse effects. 2. Blood pressure/pulse rate. 3. Trends in hematology, blood biochemistry and urinalysis.

Countries

Japan

Contacts

Public ContactMisato Ota

Kuki Sangyo Co., Ltd. R&D Medicinal Department

m_oota@kuki-info.co.jp059-350-2050

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026